Concepts (184)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Adenoviridae
- Administration, Intravenous
- Adolescent
- ADP-ribosyl Cyclase 1
- Adult
- Aged
- Aged, 80 and over
- Anemia, Sickle Cell
- Animals
- Antigen-Presenting Cells
- Antigens, CD19
- Antigens, CD7
- Antigens, Neoplasm
- Apoptosis
- Autoimmunity
- B7-1 Antigen
- B7-2 Antigen
- beta 2-Microglobulin
- Biomarkers
- B-Lymphocyte Subsets
- B-Lymphocytes, Regulatory
- Bone Marrow
- Bone Marrow Diseases
- Burkitt Lymphoma
- Career Choice
- Case-Control Studies
- CD24 Antigen
- CD4-Positive T-Lymphocytes
- CD5 Antigens
- CD8-Positive T-Lymphocytes
- Cell- and Tissue-Based Therapy
- Cell Communication
- Cell Line, Tumor
- Cell Proliferation
- Cells, Cultured
- Child
- Child, Preschool
- Chronic Disease
- Coculture Techniques
- Colony-Forming Units Assay
- Combined Modality Therapy
- Cord Blood Stem Cell Transplantation
- Cost of Illness
- Cost-Benefit Analysis
- Cystic Fibrosis
- Cytokines
- Cytomegalovirus
- Cytomegalovirus Infections
- Cytotoxicity, Immunologic
- Dendritic Cells
- Disease Models, Animal
- Down Syndrome
- Drug Evaluation, Preclinical
- Enzyme-Linked Immunosorbent Assay
- Epstein-Barr Virus Infections
- Feasibility Studies
- Female
- Flow Cytometry
- Follow-Up Studies
- Forecasting
- Gene Expression
- Gene Silencing
- Genetic Association Studies
- Genetic Diseases, Inborn
- Genetic Engineering
- Genetic Testing
- Genetic Therapy
- Genetic Vectors
- Genomics
- Graft Rejection
- Graft vs Host Disease
- Health Services Accessibility
- Hematologic Neoplasms
- Hematology
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cells
- Herpesvirus 4, Human
- Histocompatibility Antigens Class I
- HLA Antigens
- HLA-A2 Antigen
- Humans
- Imidazoles
- Immune Evasion
- Immunity
- Immunoglobulin M
- Immunologic Memory
- Immunomodulation
- Immunophenotyping
- Immunotherapy
- Immunotherapy, Adoptive
- Infant
- Infant, Newborn
| - Infant, Premature
- Infant, Premature, Diseases
- Inflammation Mediators
- Infusions, Intravenous
- Inhibitor of Apoptosis Proteins
- Interferon-gamma
- Interleukin-10
- Interleukin-6
- Killer Cells, Natural
- Lectins, C-Type
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Myeloid, Acute
- Leukocytes, Mononuclear
- Leukocytosis
- Lymphocyte Activation
- Lymphocyte Count
- Lymphocyte Depletion
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoproliferative Disorders
- Male
- Medically Underserved Area
- Mice
- Mice, SCID
- Middle Aged
- Minority Groups
- Mutation
- Myeloid Cells
- Myeloproliferative Disorders
- Neoplasm Proteins
- Neoplasm Recurrence, Local
- Neoplasms
- Neutropenia
- Organ Transplantation
- Patient Safety
- Pediatrics
- Peptide Fragments
- Personnel Selection
- Phosphorylation
- Positron Emission Tomography Computed Tomography
- Poverty
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Pregnancy
- Prognosis
- Protein Domains
- Pyridazines
- Receptors, Antigen, T-Cell
- Receptors, KIR
- Recombinant Fusion Proteins
- Recurrence
- Regenerative Medicine
- Retrospective Studies
- Retroviridae
- Risk Assessment
- Rituximab
- Salvage Therapy
- Siblings
- Signal Transduction
- Smad Proteins
- Societies, Medical
- T-Cell Antigen Receptor Specificity
- Thrombocytopenia
- T-Lymphocytes
- T-Lymphocytes, Cytotoxic
- T-Lymphocytes, Regulatory
- Transduction, Genetic
- Transforming Growth Factor beta
- Transplantation Chimera
- Transplantation Conditioning
- Transplantation, Autologous
- Transplantation, Heterologous
- Transplantation, Homologous
- Treatment Outcome
- Tumor Cells, Cultured
- Tumor Microenvironment
- Tumor Necrosis Factor Receptor Superfamily, Member 7
- United States
- United States Food and Drug Administration
- Vaccination
- Vaccinia virus
- Viral Matrix Proteins
- Virus Activation
- Vulnerable Populations
- WT1 Proteins
- Xenograft Model Antitumor Assays
- Young Adult
|
ROUCE's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(66)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_